RxVantage Acquires onPoint Oncology

November 10, 2020

RxVantage has acquired onPoint Oncology, a provider of oncology reimbursement data and analytics, with onPoint operating as a wholly owned subsidiary. The acquisition integrates onPoint's revenue-cycle data and reimbursement insights into RxVantage's digital platform to expand capabilities for oncology practices and life science customers.

Buyers
RxVantage
Targets
onPoint Oncology
Location
Ohio, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.